http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103446043-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1e7c22862e78d781bdb07a2c802ffbb4 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-06 |
| filingDate | 2012-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2015-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b31a9e19a452f258dfe3190b06b3c500 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_caea249cbc565ab707b56ae92a3dd5d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba098ae67239de76aebdc1b505bc0342 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6568aa0d365e80623dce7e43619a9f40 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_17482f34585eb8e6f79cc8a8c14bceb6 |
| publicationDate | 2015-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-103446043-B |
| titleOfInvention | In-situ gel injection implant |
| abstract | The invention mainly provides an in-situ gel injection implant. The implant is mainly composed of drugs, homopolymers or copolymers taking lactide, caprolactone or trimethylene carbonate as the monomers, and an organic solvent, which is mutually soluble with water. The drug transmission system can be injected into the subcutaneous parts, muscles, or diseased regions, and then a solid, namely an in-situ controlled-release implant, is formed through the solvent exchange. Through adjusting the ratios and molecular weights of each monomer and the prescription composition, the drugs can be released from one month to one year. |
| priorityDate | 2012-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 77.